Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared to those on other diabetes medications The protective effects were ...

There is currently no known cure for dementia, as Xu notes. But up to half of all dementia cases might be preventable, and scientists have identified over a dozen modifiable risk factors that ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia.

By Stephen Beech. Weight loss drug Ozempic may also reduce the risk of dementia, suggests a new study.. American researchers found that semaglutide - the active ingredient in Ozempic and another ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood sugar and aid weight loss — could significantly cut dementia risk ...